PNC’s third quarter results for 2025 were met with a negative market reaction, despite revenue and GAAP earnings per share ...
Detailed price information for Janux Therapeutics Inc (JANX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback